About Yehuda Handelsman, MD, FACP, FACE, FNLA
Dr. Yehuda Handelsman is the medical director and principal investigator of the Metabolic Institute of America and an endocrinologist in solo private practice in Tarzana, California, where he developed and successfully utilizes a comprehensive and unique, multiple-intervention approach to the cardiometabolic high risk patient, preventing and managing obesity, diabetes, and cardiovascular disease. He has been listed repeatedly in “Top Doctors of Los Angeles”, “Southern California Super Doctors” and “Best Doctors of America”.
Dr Handelsman is the IP-President of the American Association of Clinical Endocrinologists, and Chancellor of the American College of Endocrinology. He is chair and program director of the annual World Congress on Insulin Resistance, Diabetes & Cardiovascular Disease; chair of the International Committee for Insulin Resistance; and senior scientific consultant for the Metabolic Endocrine Education Foundation. He has published extensively, performed research, and is a frequent lecturer on diabetes and its comprehensive treatment, focusing on a comprehensive approach to managing diabetes - controlling obesity, HTN, lipids, and the prevention of kidney disease and cardiovascular disease. Handelsman has also been a national and international consultant, and recognized expert on insulin resistance, metabolic syndromes, pre-diabetes, incretins and gut hormones, the gut-brain connection, and multi-hormonal obesity. He has also consulted and lectured on lipodystrophy, thyroid and osteoporosis.
Handelsman is an associate editor of the Journal of Diabetes. He frequently serves as guest editor for multiple publications, recently for the Journal of Clinical Hypertension (JCH), Metabolic Syndrome and Related Disorders, and Postgraduate Medicine. He is an editorial board member of Clinical Endocrine News, and a member of the editorial advisory panel of Treatment Strategies – Diabetes of the Cambridge Research Center, United Kingdom.
He chairs the American Association of Clinical Endocrinologists (AACE) Diabetes Scientific Committee and the AACE/ACE (American College of Endocrinology) Comprehensive Diabetes Guidelines, and is a member of the AACE Lipid Guidelines Committee. He has been a chair, member, co-author, and reviewer of many AACE/ACE national guidelines, algorithms, and position statements on obesity, pre-diabetes, diabetes, lipids, and hypertension. Dr. Handelsman is a member of several medical associations, such as the American College of Endocrinology, the American Diabetes Association, the National Osteoporosis Foundation, the American Thyroid Association, the Academy of Thyroidologists, the American College of Physicians, Los Angeles & California Medical Associations, and the American Medical Association, as well as the National Lipid Association; and he is a board member of the Pacific Lipid Association.
Dr. Handelsman is a Summa Cum Laude graduate of the University of the Pacific in Stockton, California. He is a Fellow of the American College of Endocrinology, the American College of Physicians, and the National Lipid Association. Dr. Handelsman earned his doctor of medicine degree from Tel Aviv University Sackler Faculty of Medicine in Israel. He completed a subsequent internship and residency in internal medicine at New York Infirmary Beekman Downtown Hospital under the supervision of New York University. His fellowship in diabetes and endocrinology was conducted at the University of Southern California Medical School in Los Angeles.